Royalty Pharma Plc Cash Flow Reinvestment Rate
Royalty Pharma Plc cash flow reinvestment rate. Royalty Pharma Plc (RPRX) has a Cash Flow Reinvestment Rate of 0.62x as of March 2026, reinvesting $470.17 Million (capex $0.00 plus investments $-470.17 Million) from operating cash flow of $760.54 Million. See Royalty Pharma Plc (RPRX) flexibility index to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Royalty Pharma Plc (2002–2025)
Cash flow reinvestment rate of Royalty Pharma Plc from 2002 to 2025. Historical reinvestment intensity for Royalty Pharma Plc across 11 annual periods. Explore Royalty Pharma Plc (RPRX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Royalty Pharma Plc Cash Flow Reinvestment Rate by Year (2002–2025)
Royalty Pharma Plc cash flow reinvestment rate by year from 2002 to 2025. Year-by-year capital reinvestment analysis for Royalty Pharma Plc. For the full cash flow conversion analysis, see Royalty Pharma Plc cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | $1.36 Billion | $2.49 Billion | $0.00 | ▼ -43.3% |
| 2024 | 0.97x | $2.68 Billion | $2.77 Billion | $0.00 | ▲ +4.2% |
| 2023 | 0.93x | $2.77 Billion | $2.99 Billion | $2.12 Billion | ▼ -37.7% |
| 2022 | 1.49x | $3.19 Billion | $2.14 Billion | $2.04 Billion | ▲ +64.0% |
| 2021 | 0.91x | $1.83 Billion | $2.02 Billion | $523.00K | ▼ -65.1% |
| 2020 | 2.60x | $5.29 Billion | $2.03 Billion | $2.20 Billion | ▲ +13.0% |
| 2019 | 2.30x | $3.84 Billion | $1.67 Billion | $1.72 Billion | ▲ +342.1% |
| 2018 | 0.52x | $842.61 Million | $1.62 Billion | $269.59 Million | ▼ -74.3% |
| 2017 | 2.03x | $2.88 Billion | $1.42 Billion | $2.29 Billion | — |
| 2003 | 0.00x | $0.00 | $11.15 Million | $0.00 | ▼ -100.0% |
| 2002 | 0.01x | $49.00K | $8.45 Million | $49.00K | — |